These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 16489684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.
    Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C.
    Oncogene; 2013 Mar 21; 32(12):1549-59. PubMed ID: 22641218
    [Abstract] [Full Text] [Related]

  • 12. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE, Bergström D, Hermansson A, Bergenstråhle A, Nakao A, Westermark B, ten Dijke P.
    Mol Cell Endocrinol; 1999 Jul 20; 153(1-2):79-90. PubMed ID: 10459856
    [Abstract] [Full Text] [Related]

  • 13. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 14. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer].
    Lu B, Zhou YN, Li Q, Wu ZQ, Zhang ZY, Ji R, Guo QH, Liu W.
    Ai Zheng; 2009 May 01; 28(5):538-42. PubMed ID: 19624886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-β signaling pathway in Marfan's syndrome: a preliminary histopathological study.
    Yuan SM, Ma HH, Zhang RS, Jing H.
    Vasa; 2011 Sep 01; 40(5):369-74. PubMed ID: 21948779
    [Abstract] [Full Text] [Related]

  • 18. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ.
    PLoS One; 2013 Sep 01; 8(5):e63436. PubMed ID: 23704908
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.
    J Biol Chem; 1997 Aug 22; 272(34):21187-94. PubMed ID: 9261125
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin plus norcantharidin alter the expression of TGF-β1/Smads signaling pathway in hepatocellular carcinoma.
    Li KY, Shi CX, Huang JZ, Tang KL.
    Bratisl Lek Listy; 2017 Aug 22; 118(2):85-88. PubMed ID: 28814088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.